Latest News about GILD

Recent news which mentions GILD

...

26 27 28 29 30 31 32 33 Next >

GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead

February 02, 2022

The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales

February 02, 2022

Gilead Q4 Earnings Highlights: Remdesivir Sales Fall 30%, Raises Dividend, FY22 EPS Below Estimates

February 02, 2022

Gilead Sciences (GILD) Q4 2021 Earnings Call Transcript

February 02, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

February 01, 2022

Gilead earnings slammed by legal settlement, stock falls

February 01, 2022

Gilead Sciences: Q4 Earnings Insights

February 01, 2022

Is AbbVie Stock a Buy Now?

February 01, 2022

What This FDA News Could Mean for Pfizer

February 01, 2022

Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates

February 01, 2022

10 Health Care Stocks Whale Activity In Today's Session

January 31, 2022

How to Invest in Biotech When Deep Value Has no Discernible Meaning

January 31, 2022

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News

January 31, 2022

Is Gilead Sciences Stock a Buy Now?

January 31, 2022

3 Growth ETFs to Consider Buying During This Correction

January 29, 2022

What 5 Analyst Ratings Have To Say About Gilead Sciences

January 28, 2022

The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data

January 26, 2022

FDA Puts Clinical Hold On Gilead's Magrolimab/Azacitidine Combo Trials In Blood Cancer Settings

January 26, 2022

Why Sierra Oncology Stock Is On Fire Today

January 25, 2022

FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why

January 24, 2022

A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge

January 24, 2022

FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression

January 24, 2022

Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field

January 20, 2022

South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing

January 20, 2022

We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone

January 20, 2022

Gilead Alleges Counterfeiting Network Sold Fake HIV Drugs

January 19, 2022

Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US

January 18, 2022

3 Pharma Stocks With Especially Juicy Dividends

January 16, 2022

2 Top Healthcare Stocks to Buy Right Now

January 14, 2022

4 Biotech Acquisitions We'd Like to See in 2022

January 14, 2022

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.